Evidence map›Paper›PMID 39745312›Full record

ArticleDiseases of the colon and rectum2025

Rise in Minimally Invasive Surgery for Colorectal Cancer Is Associated With Adoption of Robotic Surgery.

Naveen Manisundaram, Christopher P Childers, Chung-Yuan Hu, Abhineet Uppal, Tsuyoshi Konishi, Brian K Bednarski, Michael G White, Oliver Peacock, Y Nancy You, George J Chang

Abstract readVideo-Audio Media
In one paragraph

Article in Diseases of the colon and rectum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Towards safer colorectal surgery worldwide: Outcomes and benchmarks from the ESCP CORREA 2022 audit.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2025
    Article
  9. Article
  10. Article
  11. Surgical treatment of colorectal cancer: A multidimensional review.World journal of gastrointestinal surgery · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Naveen ManisundaramDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0003-2532-3247
Christopher P ChildersDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chung-Yuan HuDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abhineet UppalDepartment of Surgery, Emory University School of Medicine, Atlanta, Georgia.
Tsuyoshi KonishiDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Brian K BednarskiDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Michael G WhiteDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Oliver PeacockDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Y Nancy YouDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
George J ChangDepartment of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-9758-5361

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
TRAINING OF ACADEMIC SURGICAL ONCOLOGISTST32CA009599 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Ashley M Holder, Jennifer A. Wargo · 1988 to 2026
$13.2M
CTSA K12 Program at The University of Texas Health Science Center at HoustonK12TR004908 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Charles C Miller, JON E. TYSON · 2024 to 2026
$2.9M
National Institute of Health / National Cancer Institute 5T32CA009599-33NCATS NIH HHS K12 TR004908NCI NIH HHS P30 CA016672NCI NIH HHS T32 CA009599
6 · The paper itself

Abstract

backgroundMinimally invasive surgery is associated with improved short-term outcomes and similar long-term oncologic outcomes for patients with colorectal cancer compared with open surgery. Although the robotic approach has ergonomic and technical benefits, how it has impacted the utilization of traditional laparoscopic surgery and minimally invasive surgery overall is unclear.

objectiveDescribe trends in open, robotic, and laparoscopic approaches for colorectal cancer resections and examine factors associated with minimally invasive surgery.

designRetrospective cohort study using data from the National Cancer Database from 2010 to 2020.

settingCommission on Cancer-accredited US facilities. PATIENTS: Patients diagnosed with nonmetastatic colon or rectal adenocarcinoma.

main outcome measuresSurgical approach rates (open, robotic, and laparoscopic).

resultsWe identified 475,001 patients diagnosed with nonmetastatic colorectal adenocarcinoma, of whom 192,237 (40.5%) underwent open surgery, 64,945 (13.7%) underwent robotic surgery, and 217,819 (45.9%) underwent laparoscopic surgery. For colon cancer, laparoscopic minimally invasive surgery use steadily increased, with a peak prevalence of 54.0% in 2016, and total minimally invasive surgery (robotic + laparoscopic) was performed more often than open surgery from 2013 through 2020. For rectal cancer, laparoscopic minimally invasive surgery had a peak prevalence of 37.2% in 2014 and declined from 2014 through 2020; robotic surgery prevalence increased throughout the study period (5.5% in 2010, 24.7% in 2015, and 48.8% in 2020). Minimally invasive surgery use increased in facilities performing robotic surgery every year during the study period. For both colon and rectal cancer, the use of open surgery decreased across all facilities throughout the study period. LIMITATIONS: This study used the National Cancer Database, which may not be generalizable to non-Commission on Cancer institutions.

conclusionsMinimally invasive surgery steadily increased across all facilities from 2010 through 2020. Open resections declined, laparoscopic resections plateaued, and robotic resections increased for colon and rectal cancer. Minimally invasive surgery increases may be driven by increases in robot-assisted surgery. See Video Abstract. EL AUMENTO DE LA CIRUGA MNIMAMENTE INVASIVA PARA EL CNCER COLORRECTAL SE ASOCIA CON LA ADOPCIN A LA CIRUGA ROBTICA: ANTECEDENTES:La cirugía mínimamente invasiva se asocia con mejores resultados a corto plazo y resultados oncológicos similares a largo plazo para pacientes con cáncer colorrectal en comparación con la cirugía abierta. Aunque el abordaje robótico tiene beneficios ergonómicos y técnicos, no está claro cómo ha afectado la utilización de la cirugía laparoscópica tradicional y la cirugía mínimamente invasiva en general.OBJETIVO:Describir las tendencias en los abordajes abiertos, robóticos y laparoscópicos para las resecciones de cáncer colorrectal y examinar los factores asociados con la cirugía mínimamente invasiva.DISEÑO:Estudio de cohorte retrospectivo utilizando datos de la Base de Datos Nacional del Cáncer desde 2010 hasta 2020.ESCENARIO:Centros estadounidenses acreditados por la Comisión sobre el Cáncer.PACIENTES:Pacientes diagnosticados con adenocarcinoma de colon o recto no metastásico.PRINCIPALES MEDIDAS DE VALORACIÓN:Tasas de abordaje quirúrgico (abierto, robótico, laparoscópico).RESULTADOS:Identificamos 475.001 pacientes con diagnóstico de adenocarcinoma colorrectal no metastásico, de los cuales 192.237 (40,5%) se sometieron a cirugía abierta, 64.945 (13,7%) se sometieron a cirugía robótica y 217.819 (45,9%) se sometieron a cirugía laparoscópica. Para el cáncer de colon, el uso de cirugía mínimamente invasiva laparoscópica aumentó de manera constante, con una prevalencia máxima del 54,0% en 2016, y la cirugía mínimamente invasiva total (robótica + laparoscópica) se realizó con mayor frecuencia que la cirugía abierta desde 2013 hasta 2020. Para el cáncer de recto, la cirugía mínimamente invasiva laparoscópica tuvo una prevalencia máxima del 37,2% en 2014 y disminuyó desde 2014 hasta 2020; La prevalencia de la cirugía robótica aumentó durante el período de estudio (5,5 % en 2010, 24,7 % en 2015, 48,8 % en 2020). El uso de cirugía mínimamente invasiva aumentó en los centros que realizan cirugía robótica cada año durante el período de estudio. Tanto para el cáncer de colon como para el cáncer de recto, el uso de cirugía abierta disminuyó en todos los centros durante el período de estudio.LIMITACIONES:Se utilizó la base de datos nacional sobre el cáncer, que puede no ser generalizable a instituciones que no pertenecen a la Comisión sobre el Cáncer.CONCLUSIONES:La cirugía mínimamente invasiva aumentó de manera constante en todos los centros entre 2010 y 2020. Las resecciones abiertas disminuyeron, las resecciones laparoscópicas se estabilizaron y las resecciones robóticas aumentaron para el cáncer de colon y recto. Los aumentos de la cirugía mínimamente invasiva pueden estar impulsados por aumentos en la cirugía asistida por robot. (Traducción--Ingrid Melo ).

Indexed as

AdenocarcinomaColorectal NeoplasmsLaparoscopyMinimally Invasive Surgical ProceduresRectal NeoplasmsRobotic Surgical ProceduresAgedColectomyFemaleHumansMaleMiddle AgedRetrospective StudiesUnited States

Identifiers

PMID39745312
PMCPMC12335190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.